Navigation Links
Global Med Technologies(R), Inc.'s Inlog Subsidiary Licenses Its Leading Laboratory Information System to Gabriel Martin Hospital of Saint-Paul de la Reunion
Date:11/6/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the most ... this beloved performer continues to roll along with no signs ... legendary groups: Wings and The Beatles, has been celebrating his ... the “Out There” tour and has continually added new stops ...
(Date:5/4/2015)... New findings released today from a poll conducted ... people diagnosed with a brain tumor needed more information ... at the time of diagnosis, and had only a ... course of treatment. The release of these findings corresponds ... volunteer network, the ABTA CommYOUnity™, dedicated to serving the ...
(Date:5/4/2015)... Fork, UT (PRWEB) May 04, 2015 ... surgery (up to $3,000) of one patient receiving care at ... of Utah. The procedure must be performed by July ... (willing to pay in full up front and forego the ... U.S. becomes more economically burdensome every year, and it devastates ...
(Date:5/4/2015)... Sheltering Arms announced that it has ... The Mother Hale Learning Center meets a tremendous need ... Sheltering Arms will begin operating the site immediately and ... the center. , Opened in 2006, the Mother Hale ... five years, many of whom come from high-need backgrounds. ...
(Date:5/4/2015)... Helena, MT (PRWEB) May 04, 2015 ... partnered with Care to Care, LLC to manage outpatient ... will help New West Medicare ensure its members are ... avoid unnecessary radiation. , Working closely with New West ... in promoting the safe use of advanced imaging and ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... , TUESDAY, Nov. 16 (HealthDay News) -- Antibiotics may help ... drugs also come with the risk of side effects, concludes ... and 10 percent of children experience side effects, such as ... "If you have 100 healthy children with an ...
... advanced liver cancer with the agent doxorubicin (routinely used ... sorafenib resulted in greater overall survival and progression-free survival, ... according to a study in the November 17 issue ... is the sixth most common malignancy worldwide, with approximately ...
... Mich. Transforming vacant urban lots into farms and ... of their fruits and vegetables. As city officials ... study indicates that a combination of urban farms, community ... to extend the growing season could supply local ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... open clogged arteries in addition to standard drug therapy ... in diabetics with heart disease, new research finds. ... Association,s annual meeting in Chicago, is part of a ...
... Nov. 16 (HealthDay News) -- Implantable cardioverter defibrillators (ICDs) that ... for necessary upgrades -- can be safely used again for ... on a small study of 31 patients in India who ... from other patients. The study, led by Dr. Behzad ...
... Researchers have found that many cystic fibrosis (CF) patients in Canada ... , which can increase the risk of death or the need ... strain, first identified in the U.K., is yet common among ... CF patients in Ontario and found that 102 of them were ...
Cached Medicine News:Health News:Antibiotics a Mixed Bag for Kids' Ear Infections: Analysis 2Health News:Antibiotics a Mixed Bag for Kids' Ear Infections: Analysis 3Health News:Combination therapy improves survival time for patients with advanced liver cancer 2Health News:Detroit's urban farms could provide a majority of produce for local residents 2Health News:Adding Surgery to Meds May Help Diabetics With Heart Disease 2Health News:Old Defibrillators Safe for Re-use 2Health News:Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada 2
(Date:5/4/2015)... TAIPEI , May 4, 2015 ... partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... BAX ) jointly announced that Baxter has ... European Medicines Agency (EMA) for MM-398 (irinotecan liposome ... metastatic adenocarcinoma of the pancreas who have been ...
(Date:5/4/2015)... DOYLESTOWN, Pa. , May 4, 2015  Makindus, ... announced today that the European Medicines Agency (EMA) has ... for the treatment of Stargardt,s Disease. "We ... for MI-100 to treat Stargardt,s disease in place for ... our development program in the United States ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... Delcath Systems, Inc. (Nasdaq: DCTH ) announced ... discuss its recent corporate developments and update its progress on ... President and Chief Executive Officer will host the call. ... 800-322-5044 for domestic participants and 617-614-4927 for international participants, both ...
... 2011 CVS Caremark Corporation (NYSE: CVS ... present at two investor conferences in the month of ... CVS Caremark, will be making a presentation to investors ... on Thursday, November 10th, at approximately 10:00 a.m. MST ...
Cached Medicine Technology:Delcath Systems to Report Third Quarter Progress and Conduct Conference Call 2Delcath Systems to Report Third Quarter Progress and Conduct Conference Call 3CVS Caremark to Present at Upcoming Conferences 2
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate ... Its design allows for a very close ... with a low voltage power source such ... field in volts/cm. The result is exceptionally ...
... RNA from agarose gels to hybridization membranes ... speed and efficiency of transfer by allowing ... ,Part of an integrated system allowing electrophoresis, ... 2.5 hours, versus 29 hours required for ...
... Transfers depurinated DNA and RNA from agarose ... as 15 minutes ,Increases speed and efficiency ... be applied to gel ,Part of an ... and UV crosslinking in 2.5 hours, versus ...
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
Medicine Products: